PIK3CA and breast cancer: Activation of the phosphatidylinositol 3-kinase (PI3K) pathway (Miller et al. 2011a; Tryfonidis et al. 2016), the most frequently altered signalling route in breast cancer (Cancer Genome Atlas 2012), is one of the identified mechanisms that may contribute to endocrine resistance.